[{"orgOrder":0,"company":"Metabolic Technologies","sponsor":"University of Tampa","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"U.S.A","productType":"Miscellaneous","year":"2014","type":"Inapplicable","leadProduct":"Adenosine Triphosphate","moa":"Tyrosine-protein kinase ABL1; ATP-binding cassette sub-family C member 6; ATP-binding cassette sub-family C member 4; Multidrug resistance-associated protein 1; Cystic fibrosis transmembrane conductance regulator; Phosphatidylinositol 4,5-bisphosphate 3-k||Tyrosine-protein kinase ABL1; ATP-binding cassette sub-family C member 6; ATP-binding cassette sub-family C member 4; Multidrug resistance-associated protein 1; Cystic fibrosis transmembrane conductance regulator; Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform; Casein kinase II subunit alpha; Casein kinase II subunit beta; P2Y purinoceptor 11; Serine\/threonine-protein phosphatase 5; Tyrosine-protein kinase ABL2; Phospholipid-transporting ATPase ABCA1; Acetyl-coenzyme A synthetase, cytoplasmic; ALK tyrosine kinase receptor; NEDD8-activating enzyme E1 regulatory subunit; 5'-AMP-activated protein kinase catalytic subunit alpha-1; Serine\/threonine-protein kinase A-Raf; Activin receptor type-1-like; Long-chain-fatty-acid--CoA ligase 1; Cytosolic purine 5'-nucleotidase; ATPase GET3; ATP-binding cassette sub-family C member 9; RAC-alpha serine\/threonine-protein kinase; Beta-adrenergic receptor kinase 1; Apoptotic protease-activating factor 1; Acetyl-coenzyme A ","graph1":"Musculoskeletal","graph2":"Undisclosed","graph3":"Metabolic Technologies","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Metabolic Technologies \/ University of Tampa","highestDevelopmentStatusID":"1","companyTruncated":"Metabolic Technologies \/ University of Tampa"},{"orgOrder":0,"company":"EIPICO","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"EGYPT","productType":"Miscellaneous","year":"2025","type":"Inapplicable","leadProduct":"Adenosine Triphosphate","moa":"Purinergic P2 receptor","graph1":"Neurology","graph2":"Phase IV","graph3":"EIPICO","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Injection","sponsorNew":"EIPICO \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"EIPICO \/ Undisclosed"}]
Find Clinical Drug Pipeline Developments & Deals for Adenosine Triphosphate
Filters
×
FILTER:
Company Name
Year
DEALS // DEV.
Country
Sponsor
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Reset All
